159 related articles for article (PubMed ID: 36739413)
1. Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
Yang K; Hu H; Wu J; Wang H; Guo Z; Yu W; Yao L; Ding F; Zhou T; Wang W; Wang Y; Liu L; Guo J; Zhu S; Zhang X; Cao S; Lou F; Niu Y; Ye D; He Z
Mol Cancer; 2023 Feb; 22(1):25. PubMed ID: 36739413
[TBL] [Abstract][Full Text] [Related]
2. UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA.
Wang P; Shi Y; Zhang J; Shou J; Zhang M; Zou D; Liang Y; Li J; Tan Y; Zhang M; Bi X; Zhou L; Ci W; Li X
EBioMedicine; 2023 Mar; 89():104437. PubMed ID: 36758479
[TBL] [Abstract][Full Text] [Related]
3. Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction.
Mochizuki H; Shapiro SG; Breen M
Vet Pathol; 2016 Jul; 53(4):764-72. PubMed ID: 26574558
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
[TBL] [Abstract][Full Text] [Related]
6. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
[TBL] [Abstract][Full Text] [Related]
7. The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.
Kwak KW; Kim SH; Lee HM
J Korean Med Sci; 2009 Dec; 24(6):1139-44. PubMed ID: 19949672
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma.
Gayed BA; Seideman C; Lotan Y
J Urol; 2013 Oct; 190(4):1181-6. PubMed ID: 23583531
[TBL] [Abstract][Full Text] [Related]
9. [Tumor cell-based glycolytic metabolism and single-cell sequencing of urinary exfoliated cells for the diagnosis and molecular profiling of urothelial carcinoma].
Xiao XY; Zhao H; Guo HQ; Wang C; Sun Y; Chang XX; Zhao LL; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):472-479. PubMed ID: 37106289
[No Abstract] [Full Text] [Related]
10. Role of Tetrasomy for the Diagnosis of Urothelial Carcinoma Using UroVysion Fluorescent In Situ Hybridization.
Zhou AG; Liu Y; Cyr MS; Garver J; Woda BA; Cosar EF; Hutchinson LM
Arch Pathol Lab Med; 2016 Jun; 140(6):552-9. PubMed ID: 27232347
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma].
Liu JY; Peng X; Ning XH; Li T; Peng SH; Wang JY; Liu SJ; Ding Y; Cai L; Gong K
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):585-589. PubMed ID: 28816270
[TBL] [Abstract][Full Text] [Related]
12. Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology.
Huysentruyt CJ; Baldewijns MM; Rüland AM; Tonk RJ; Vervoort PS; Smits KM; van de Beek C; Speel EJ
Histopathology; 2011 Jun; 58(7):1048-53. PubMed ID: 21707706
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Detection of Urothelial Carcinoma by Cost-effective Low-coverage Whole-genome Sequencing from Urine-Exfoliated Cell DNA.
Zeng S; Ying Y; Xing N; Wang B; Qian Z; Zhou Z; Zhang Z; Xu W; Wang H; Dai L; Gao L; Zhou T; Ji J; Xu C
Clin Cancer Res; 2020 Nov; 26(21):5646-5654. PubMed ID: 33037018
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
[TBL] [Abstract][Full Text] [Related]
15. A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets.
Breen V; Kasabov N; Kamat AM; Jacobson E; Suttie JM; O'Sullivan PJ; Kavalieris L; Darling DG
BMC Med Res Methodol; 2015 May; 15():45. PubMed ID: 25962444
[TBL] [Abstract][Full Text] [Related]
16. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Todenhöfer T; Hennenlotter J; Esser M; Mohrhardt S; Tews V; Aufderklamm S; Gakis G; Kuehs U; Stenzl A; Schwentner C
Cancer Cytopathol; 2013 May; 121(5):252-60. PubMed ID: 23172833
[TBL] [Abstract][Full Text] [Related]
17. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
18. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Application of Fluorescence in Situ Hybridization in Diagnosing Urothelial Carcinoma.
Zhou H; Yan Y; Song L
Clin Lab; 2016 Oct; 62(10):2001-2009. PubMed ID: 28164542
[TBL] [Abstract][Full Text] [Related]
20. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
